Pure Global AI
Manufacturer profile

INSTITUT VIRIONSERION GMBH

TaiwanGermany11 products registeredDec 22, 2005 – Mar 27, 2006
VerifiedTFDA · Taiwan Food and Drug Administration registry
11
Total products
11
Product types
0
Active products
Mar 2006
Latest registration
Company details
Address
FRIEDRICH-BERGIUS-RING 19 D-97076 WURZBURG, GERMANY
Regulatory footprint
Search INSTITUT VIRIONSERION GMBH across other regulatory registries
ThailandEuropean UnionColombiaSouth KoreaCanadaEcuador
Recent registrations
Latest 5 products registered by this manufacturer
Veromsilon parainfluenza virus type 3 complement kit (unsterilized)
Class 1
Mar 27, 2006
Veromsilon Parainfluenza Virus Type II Complement Kit (unsterilized)
Class 1
Mar 27, 2006
Villon Hirom Influenza Virus Complement Group B (unsterilized)
Class 1
Mar 27, 2006
Velom Hirom Parainfluenza Virus Type I Complement Kit (Unsterilized)
Class 1
Mar 27, 2006
Velom Silone complement test auxiliary reagent (unsterilized)
Class 1
Mar 27, 2006
Most popular products
Products with most registrations
Veromsilon parainfluenza virus type 3 complement kit (unsterilized)
1 registrations
Veromsilon Parainfluenza Virus Type II Complement Kit (unsterilized)
1 registrations
Villon Hirom Influenza Virus Complement Group B (unsterilized)
1 registrations
Velom Hirom Parainfluenza Virus Type I Complement Kit (Unsterilized)
1 registrations
Velom Silone complement test auxiliary reagent (unsterilized)
1 registrations
Authorized representatives
Taiwan authorized representatives for this manufacturer
UNISYS BIOMEDICAL CO.
11 products
Recent registered products
Most recent products (showing top 20)
Veromsilon parainfluenza virus type 3 complement kit (unsterilized)
Registered: Mar 27, 2006 • Expires: Mar 27, 2016
Cancelled
Risk Class
Class 1
AR
UNISYS BIOMEDICAL CO.
Veromsilon Parainfluenza Virus Type II Complement Kit (unsterilized)
Registered: Mar 27, 2006 • Expires: Mar 27, 2016
Cancelled
Risk Class
Class 1
AR
UNISYS BIOMEDICAL CO.
Villon Hirom Influenza Virus Complement Group B (unsterilized)
Registered: Mar 27, 2006 • Expires: Mar 27, 2016
Cancelled
Risk Class
Class 1
AR
UNISYS BIOMEDICAL CO.
Velom Hirom Parainfluenza Virus Type I Complement Kit (Unsterilized)
Registered: Mar 27, 2006 • Expires: Mar 27, 2016
Cancelled
Risk Class
Class 1
AR
UNISYS BIOMEDICAL CO.
Velom Silone complement test auxiliary reagent (unsterilized)
Registered: Mar 27, 2006 • Expires: Mar 27, 2016
Cancelled
Risk Class
Class 1
AR
UNISYS BIOMEDICAL CO.
Velom Shilon Influenza A Virus Complement Reagent Group
Registered: Dec 27, 2005 • Expires: Dec 27, 2010
Cancelled
Risk Class
Class 1
AR
UNISYS BIOMEDICAL CO.
Velom Hirom mumps virus complement reagent group
Registered: Dec 22, 2005 • Expires: Dec 22, 2010
Cancelled
Risk Class
Class 1
AR
UNISYS BIOMEDICAL CO.
Velomsilon adenovirus complement reagent group
Registered: Dec 22, 2005 • Expires: Dec 22, 2010
Cancelled
Risk Class
Class 1
AR
UNISYS BIOMEDICAL CO.
Veron Shironk Shachi virus complement reagent group
Registered: Dec 22, 2005 • Expires: Dec 22, 2010
Cancelled
Risk Class
Class 1
AR
UNISYS BIOMEDICAL CO.
Velom Hirom measles virus complement reagent group
Registered: Dec 22, 2005 • Expires: Dec 22, 2010
Cancelled
Risk Class
Class 1
AR
UNISYS BIOMEDICAL CO.
Velomsilone pneumoniae complement reagent group
Registered: Dec 22, 2005 • Expires: Dec 22, 2010
Cancelled
Risk Class
Class 1
AR
UNISYS BIOMEDICAL CO.
About this profile

Explore comprehensive manufacturer profile for INSTITUT VIRIONSERION GMBH based in Germany through Pure Global AI's free Taiwan medical device database. This manufacturer has 11 products registered in Taiwan across 11 unique product categories. Their regulatory history spans from Dec 22, 2005 to Mar 27, 2006.

This page provides detailed insights including 5 recent product registrations, 5 most popular products with Veromsilon parainfluenza virus type 3 complement kit (unsterilized) having 1 registrations, and 1 authorized representatives including UNISYS BIOMEDICAL CO.. Pure Global AI offers free access to Taiwan's medical device database, enabling global MedTech companies to analyze market dynamics and identify opportunities.